The use of non-narcotic pain medication in pediatric gastroenterology

Adrian Miranda1, Miguel Saps

  • 1Division of Gastroenterology and Hepatology, Department of Pediatrics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA, amiranda@mcw.edu.

Paediatric Drugs
|June 20, 2014
PubMed

Insights

This review examines non-narcotic pain medications for chronic abdominal pain in children, highlighting the limited pediatric research and reliance on adult data for treatment decisions.

Area of Science:

  • Pediatric Gastroenterology
  • Pain Management
  • Pharmacology

Background:

  • Chronic abdominal pain is common in pediatric gastroenterology, often linked to functional disorders like irritable bowel syndrome.
  • Understanding pathophysiological mechanisms for these disorders is limited, hindering pharmacological therapy development.
  • Pain signaling in the gastrointestinal tract is complex, with few targeted therapies available.

Purpose of the Study:

  • To review common non-narcotic pharmacological treatments for chronic abdominal pain in children.
  • To evaluate the evidence supporting or refuting the use of these treatments based on available literature.
  • To address the scarcity of pediatric-specific studies by considering adult data.

Main Methods:

  • Comprehensive literature review of pharmacological and alternative therapies for chronic abdominal pain.
  • Focus on non-narcotic treatments relevant to pediatric populations.
  • Analysis of evidence from both pediatric and adult studies where pediatric data is limited.

Main Results:

  • The development of effective pharmacological therapies is hampered by a lack of understanding of underlying mechanisms.
  • Treatment responses are variable, possibly due to the heterogeneity of functional abdominal pain disorders.
  • A significant gap exists in high-quality randomized clinical trials for pediatric chronic abdominal pain treatments.

Conclusions:

  • Evidence for many treatments is derived from adult studies due to a paucity of pediatric research.
  • Treatment decisions for pediatric chronic abdominal pain often rely on empirical data and adult guidelines.
  • Further pediatric-specific research is crucial to establish evidence-based therapeutic strategies.

Related Concept Videos

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
1.0K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
955
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.6K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.6K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K